Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -5.65 is 90% above its 5-year average of -54.48, near the high end of its 5-year range (-171.62–-5.65).
45.15% above its 12-month average of -10.30.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -0.48.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 29 comparable quarters.
EARNINGS PER SHARE (EPS)
-5.65
EARNINGS PER SHARE (EPS) AVG TTM
-10.30
EARNINGS PER SHARE (EPS) AVG 3Y
-22.40
EARNINGS PER SHARE (EPS) AVG 5Y
-54.48
EARNINGS PER SHARE (EPS) AVG 10Y
-76.10
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
+45.15%
CURRENT VS 3Y AVG
+74.78%
CURRENT VS 5Y AVG
+89.63%
CURRENT VS 10Y AVG
+92.58%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Quantum BioPharma Ltd.
Market Cap
$20.99M
Earnings Per Share (EPS)
-5.65
TTM Avg
-10.30
3Y Avg
-22.40
5Y Avg
-54.48
Market Cap
$21.76M
Earnings Per Share (EPS)
-10.06
TTM Avg
-13.83
3Y Avg
-22.37
5Y Avg
-34.56
Market Cap
$19.77M
Earnings Per Share (EPS)
-0.89
TTM Avg
-2.16
3Y Avg
-1.83
5Y Avg
-1.83
Market Cap
$18.97M
Earnings Per Share (EPS)
-32.95
TTM Avg
-46.02
3Y Avg
-111.83
5Y Avg
-112.54
Market Cap
$22.43M
Earnings Per Share (EPS)
-32.78
TTM Avg
-24.95
3Y Avg
-26.53
5Y Avg
-21.18
Market Cap
$22.31M
Earnings Per Share (EPS)
-1.66
TTM Avg
-1.66
3Y Avg
-2.82
5Y Avg
-25.82
Market Cap
$18.95M
Earnings Per Share (EPS)
-10.58
TTM Avg
-21.77
3Y Avg
-25.72
5Y Avg
-24.83
Market Cap
$18.65M
Earnings Per Share (EPS)
-7.26
TTM Avg
-1.65
3Y Avg
-0.89
5Y Avg
-0.63
Market Cap
$22.97M
Earnings Per Share (EPS)
-1.83
TTM Avg
-2.73
3Y Avg
-3.73
5Y Avg
-3.47
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Quantum BioPharma Ltd. (QNTM) | $20.99M | -5.65 | -10.30 | -22.40 | -54.48 |
| Modular Medical, Inc. (MODD)vs › | $21.76M | -10.06 | -13.83 | -22.37 | -34.56 |
| Actuate Therapeutics Inc (ACTU)vs › | $19.77M | -0.89 | -2.16 | -1.83 | -1.83 |
| P3 Health Partners Inc. (PIII)vs › | $18.97M | -32.95 | -46.02 | -111.83 | -112.54 |
| LeonaBio, Inc. (LONA)vs › | $22.43M | -32.78 | -24.95 | -26.53 | -21.18 |
| Aytu BioPharma, Inc. (AYTU)vs › | $22.31M | -1.66 | -1.66 | -2.82 | -25.82 |
| NextCure, Inc. (NXTC)vs › | $18.95M | -10.58 | -21.77 | -25.72 | -24.83 |
| Neuphoria Therapeutics Inc. (NEUP)vs › | $18.65M | -7.26 | -1.65 | -0.89 | -0.63 |
| Rein Therapeutics Inc. (RNTX)vs › | $22.97M | -1.83 | -2.73 | -3.73 | -3.47 |
| Estrella Immunopharma, Inc. (ESLA)vs › | $19.55M | -0.25 | -0.29 | -0.28 | -0.20 |
Trailing EPS (TTM)
$-5.65
Forward EPS (Est.)
N/A
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -8.11 |
| 2024-12-31 | -12.49 |
| 2023-12-31 | -29.39 |
| 2022-12-31 | -39.62 |
| 2021-12-31 | -65.63 |
| 2020-12-31 | -171.62 |
| 2019-12-31 | -277.33 |
| 2018-12-31 | -134.50 |
| 2017-12-31 | -22.05 |
| 2016-08-31 | -0.22 |
| 2015-08-31 | -0.24 |
